Effect of vitamin B12 on hospitalized covid-19 patients.

Phase 3

Recruiting

• Conditions: covid-19.; COVID19, virus identified; U07. 1

• Registration Number: IRCT20210515051304N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

consent
age 18-75 years
covid-19 patients
hospitalized

Exclusion Criteria

nodding ventilator
acute/chronic renal insufficiency
liver insufficiency
taking vitamin b12 in the past 3 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin B12 blood level. Timepoint: before study, first 24 hours, day 7. Method of measurement: Blood sampling.;Mortality. Timepoint: at the end of hospitalization. Method of measurement: observation.;Need for mechanical ventilation. Timepoint: at the end of hospitalization. Method of measurement: file.;Spo2. Timepoint: daily. Method of measurement: pulse oximeter.;Vit-d blood level. Timepoint: day 1. Method of measurement: lab test.